Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Eiji Miyajima"'
Autor:
Kouichi Tamura, Osamu Tochikubo, Eiji Gotoh, Eiji Miyajima, Yoshihiro Ishikawa, Satoshi Umemura
Publikováno v:
Hypertension Research.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fd5c258ce3fc4cf8e36cbbe9ce0e297
https://doi.org/10.1038/s41440-023-01281-3
https://doi.org/10.1038/s41440-023-01281-3
Autor:
Soichiro Sugiyama, Yoshimi Ota, Yoshifumi Sugiyama, Shuichi Ito, Jun Tsukiji, Yuko Matsumoto, Saori Kida, Hiroyuki Shimizu, Eiji Miyajima
Publikováno v:
Kansenshogaku Zasshi. 92:347-352
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aab32db62ac86ffb40fa7f7dd4215905
https://doi.org/10.11150/kansenshogakuzasshi.92.347
https://doi.org/10.11150/kansenshogakuzasshi.92.347
Autor:
Eiji Miyajima, Kenshiro Taniguchi, Miho Iwasa, T Ogashiwa, Hitomi Nakahata, Ai Ookawara, Katsuki Yaguchi, Wataru Shibata, Hiromi Matsumoto, Rongrong Wu, Reiko Kunisaki, Shin Inazawa, Shin Maeda, Masafumi Nishio, Hideaki Kimura, Masako Sohara, Tadashi Yamaguchi, Naoko Inagaki, Mao Okada, Ryonho Koh, Mari S. Oba, Kota Kobayashi, Hiroto Kinoshita, Aki Hayashi, Tomohiko Sasaki, Shin Yagi, Hiroki Ohge, Yuki Iizuka
Publikováno v:
Inflammatory bowel diseases. 23(11)
Background Patients with inflammatory bowel disease (IBD) occasionally require central venous catheter (CVC) placement to support a therapeutic plan. Given that CVC can predispose patients to infection, this investigation was undertaken to assess the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adcf2fec401d1c7470d1118851f21418
https://pubmed.ncbi.nlm.nih.gov/29045261
https://pubmed.ncbi.nlm.nih.gov/29045261
Autor:
Shin Maeda, Masaaki Kondo, Yu Shimoyama, Masataka Taguri, Manabu Morimoto, Satoshi Morita, Hiroyuki Fukuda, Satoshi Moriya, Akito Nozaki, Katsuaki Tanaka, Kazushi Numata, Eiji Miyajima, Mari S. Oba
Publikováno v:
Hepatology Research. 43:919-924
Aim Interleukin (IL)-28B gene polymorphism is closely linked with treatment response to peginterferon plus ribavirin combination therapy for hepatitis C virus genotype 1. However, few studies have reported its effects on therapy for genotype 2. We ai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1bf12f6bf8bc4b0fc9f9d70998a1ede
https://doi.org/10.1111/hepr.12037
https://doi.org/10.1111/hepr.12037
Autor:
Kazuya Sugimori, Eiji Miyajima, Nobuyuki Kato, Akito Nozaki, Masanori Ikeda, Masaaki Kondo, Manabu Morimoto, Kazushi Numata, Katsuaki Tanaka, Shin Maeda, Satoshi Morita
Publikováno v:
Antiviral Therapy. 15:1179-1183
Background HCV is the main causative agent of chronic liver disease, which could progress to liver cirrhosis and hepatocellular carcinoma. By using a recently developed genome-length HCV RNA replication reporter assay system, we found that hydroxyure
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d56bbc4a839d453a84cf596d8c38799b
https://doi.org/10.3851/imp1668
https://doi.org/10.3851/imp1668
Autor:
Kazushi Numata, Eiji Miyajima, Takeshi Kaneko, Nobuyuki Kato, Akito Nozaki, Masaaki Kondo, Manabu Morimoto, Takashi Oshima, Masanori Ikeda, Shin Fujisawa, Katsuaki Tanaka, Kyoko Mori, Satoshi Morita
Publikováno v:
Archives of Virology. 155:601-605
Hepatitis C virus (HCV) is the main causative agent of chronic liver disease, which may develop into liver cirrhosis and hepatocellular carcinoma. By using a recently developed reporter assay system in which genome-length HCV RNA replicates efficient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca6af2fcee7fde4b3e719ebf9013412a
https://doi.org/10.1007/s00705-010-0624-1
https://doi.org/10.1007/s00705-010-0624-1
Publikováno v:
Cardiovascular Drugs and Therapy. 14:61-66
The cardiovascular and sympatholytic effects of combination therapy with guanabenz were examined in 26 patients (48 ± 13 years old [mean ± SD]) with stage 2 and 3 hypertension. Included in the study were patients under treatment with conventional a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c3652e1fea94c6f95e565572d711e7d
https://doi.org/10.1023/a:1007895222149
https://doi.org/10.1023/a:1007895222149
Autor:
Eiji Miyajima, Yutaka Yamada
Publikováno v:
American Journal of Hypertension. 12:1195-1200
The purpose of our study was to investigate the sympathetic response to excess salt loading of 54 normotensive young adults with and without a family history of hypertension. We examined muscle sympathetic nerve activity, plasma concentration and uri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ff9aecb00d3553dba7f3689f3265c97
https://doi.org/10.1016/s0895-7061(99)00122-3
https://doi.org/10.1016/s0895-7061(99)00122-3
Publikováno v:
Hypertension. 33:1159-1163
Abstract —Because adipose tissue has high electric resistance, the amount of body fat influences ECG voltage. In this study, body fat weight of patients with essential hypertension was measured by means of the impedance method and was used to corre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::578d440eb520e9f06c7bc530efcd2dd1
https://doi.org/10.1161/01.hyp.33.5.1159
https://doi.org/10.1161/01.hyp.33.5.1159
Publikováno v:
Journal of Hypertension. 16:2101-2108
Objective To investigate the relationship between circadian changes in urinary microalbumin excretion (UAE), blood pressure (BP) and physical activity in patients with essential hypertension. Design and methods The subjects were 45 patients with esse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbc0831ab5d7a54e84e68feed1bf8409
https://doi.org/10.1097/00004872-199816121-00036
https://doi.org/10.1097/00004872-199816121-00036